CCN2 is necessary for the function of mouse embryonic fibroblasts

Experimental Cell Research

Volumn 313, Issue 5, 2007, Pages 952-964

  Kennedy, Laura ^a   Liu, Shangxi ^a   Shi wen, Xu ^b   Chen, Yunliang ^b,c   Eastwood, Mark ^c   Carter, David E ^d   Lyons, Karen M ^e   Black, Carol M ^b   Abraham, David J ^b   Leask, Andrew ^a  

^a Division of oral biology   (Canada)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF WESTMINSTER   (United Kingdom)

^d London Regional Genomics Centre   (Canada)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CCN2; Connective tissue growth factor; Embryonic fibroblasts; Tissue remodeling

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; AGGRECAN; ANTIBODY; CELL PROTEIN; CERULOPLASMIN; DIMETHYL SULFOXIDE; INTERLEUKIN 6; LIPOCALIN 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN CCN2; SYNDECAN 4; THROMBOSPONDIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONNECTIVE TISSUE; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; FIBROBLAST; GENE OVEREXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 33847241259     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.12.006     Document Type: Article

References (62)

1. Badylak S.F. The extracellular matrix as a scaffold for tissue reconstruction. Semin. Cell Dev. Biol. 13 (2002) 377-383
2. Lau L.F., and Lam S.C. The CCN family of angiogenic regulators: the integrin connection. Exp. Cell Res. 248 (1999) 44-57
3. Moussad E.E., and Brigstock D.R. Connective tissue growth factor: what's in a name?. Mol. Genet. Metab. 71 (2000) 276-292
4. Perbal B. CCN proteins: multifunctional signalling regulators. Lancet 363 (2004) 62-64
5. Leask A., and Abraham D.J. The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem. Cell Biol. 81 (2003) 355-363
6. Igarashi A., Okochi H., Bradham D.M., and Grotendorst G.R. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol. Biol. Cell 4 (1993) 637-645
7. Surveyor G.A., Wilson A.K., and Brigstock D.R. Localization of connective tissue growth factor during the period of embryo implantation in the mouse. Biol. Reprod. 59 (1998) 1207-1213
8. Friedrichsen S., Heuer H., Christ S., Winckler M., Brauer D., Bauer K., and Raivich G. CTGF expression during mouse embryonic development. Cell Tissue Res. 312 (2003) 175-188
9. Frazier K.S., and Grotendorst G.R. Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors. Int. J. Biochem. Cell Biol. 29 (1997) 153-161
10. Abraham D.J., Shiwen X., Black C.M., Sa S., Xu Y., and Leask A. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J. Biol. Chem. 275 (2000) 15220-15225
11. Blom I.E., Goldschmeding R., and Leask A. Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy?. Matrix Biol. 21 (2002) 473-482
12. Babic A.M., Chen C.C., and Lau L.F. Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol. Cell. Biol. 19 (1999) 2958-2966
13. Chen C.C., Chen N., and Lau L.F. The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J. Biol. Chem. 276 (2001) 10443-10452
14. Gao R., and Brigstock D.R. Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan. J. Biol. Chem. 279 (2004) 8848-8855
15. Chen Y., Abraham D.J., Shi-Wen X., Pearson J.D., Black C.M., Lyons K.M., and Leask A. CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin. Mol. Biol. Cell 15 (2004) 5635-5646
16. Kireeva M.L., Latinkic B.V., Kolesnikova T.V., Chen C.C., Yang G.P., Abler A.S., and Lau L.F. Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development. Exp. Cell Res. 233 (1997) 63-77
17. Gore-Hyer E., Pannu J., Smith E.A., Grotendorst G., and Trojanowska M. Selective stimulation of collagen synthesis in the presence of costimulatory insulin signaling by connective tissue growth factor in scleroderma fibroblasts. Arthritis Rheum. 48 (2003) 798-806
18. Hashimoto G., Inoki I., Fujii Y., Aoki T., Ikeda E., and Okada Y. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J. Biol. Chem. 277 (2002) 36288-36295
19. Grotendorst G.R., Rahmanie H., and Duncan M.R. Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J. 18 (2004) 469-479
20. Grotendorst G.R., and Duncan M.R. Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J. 19 (2005) 729-738
21. Shi-wen X., Stanton L.A., Kennedy L., Pala D., Chen Y., Howat S.L., Renzoni E.A., Carter D.E., Bou-Gharios G., Stratton R.J., Pearson J.D., Beier F., Lyons K.M., Black C.M., Abraham D.J., and Leask A. CCN2 is necessary for adhesive responses to transforming growth factor-beta1 in embryonic fibroblasts. J. Biol. Chem. 281 (2006) 10715-10726
22. Kireeva M.L., Lam S.C., and Lau L.F. Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin alphavbeta3. J. Biol. Chem. 273 (1998) 3090-3096
23. Lin C.G., Leu S.J., Chen N., Tebeau C.M., Lin S.X., Yeung C.Y., and Lau L.F. CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J. Biol. Chem. 278 (2003) 24200-24208
24. Lafont J., Thibout H., Dubois C., Laurent M., and Martinerie C. NOV/CCN3 induces adhesion of muscle skeletal cells and cooperates with FGF2 and IGF-1 to promote proliferation and survival. Cell Commun. Adhes. 12 (2005) 41-57
25. Ivkovic S., Yoon B.S., Popoff S.N., Safadi F.F., Libuda D.E., Stephenson R.C., Daluiski A., and Lyons K.M. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130 (2003) 2779-2791
26. Holmes A., Abraham D.J., Sa S., Shiwen X., Black C.M., and Leask A. CCN2 and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J. Biol. Chem. 276 (2001) 10594-10601
27. Leask A., Holmes A., Black C.M., and Abraham D.J. Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J. Biol. Chem. 278 (2003) 13008-13015
28. Van Beek J.P., Kennedy L., Rockel J.S., Bernier S.M., and Leask A. The induction of CCN2 by TGFbeta1 involves Ets-1. Arthritis Res. Ther. 8 (2006) R36
29. Lin L., and Kurpakus-Wheater M. Laminin alpha5 chain adhesion and signaling in conjunctival epithelial cells. Invest. Ophthalmol. Visual Sci. 43 (2002) 2615-2621
30. Feistritzer C., Kaneider N.C., Sturn D.H., and Wiedermann C.J. Syndecan-4-dependent migration of human eosinophils. Clin. Exp. Allergy 34 (2004) 696-703
31. Eastwood M., Porter R., Khan U., McGrouther G., and Brown R. Quantitative analysis of collagen gel contractile forces generated by dermal fibroblasts and the relationship to cell morphology. J. Cell. Physiol. 166 (1996) 33-42
32. Grinnell F., and Ho C.H. Transforming growth factor beta stimulates fibroblast-collagen matrix contraction by different mechanisms in mechanically loaded and unloaded matrices. Exp. Cell Res. 273 (2002) 248-255
33. Shi-Wen X., Chen Y., Denton C.P., Eastwood M., Renzoni E.A., Bou-Gharios G., Pearson J.D., Dashwood M., Du Bois R.M., Black C.M., Leask A., and Abraham D.J. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol. Biol. Cell 15 (2004) 2707-2719
34. Brown R.A., Prajapati R., McGrouther D.A., Yannas I.V., and Eastwood M. Tensional homeostasis in dermal fibroblasts: mechanical responses to mechanical loading in three-dimensional substrates. J. Cell. Physiol. 175 (1998) 323-332
35. Chen Y., Shi-Wen X., van Beek J., Kennedy L., McLeod M., Renzoni E.A., Bou-Gharios G., Wilcox-Adelman S., Goetinck P.F., Eastwood M., Black C.M., Abraham D.J., and Leask A. Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease. Am. J. Pathol. 167 (2005) 1699-1711
36. Shi-wen X., Howat S.L., Renzoni E.A., Holmes A., Pearson J.D., Dashwood M.R., Bou-Gharios G., Denton C.P., du Bois R.M., Black C.M., Leask A., and Abraham D.J. Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK/ERK. J. Biol. Chem. 279 (2004) 23098-23103
37. Holmdahl L., and Ivarsson M.L. The role of cytokines, coagulation, and fibrinolysis in peritoneal tissue repair. Eur. J. Surg. 165 (1999) 1012-1019
38. Bisset L.R., and Schmid-Grendelmeier P. Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective. Curr. Opin. Pulm. Med. 11 (2005) 35-42
39. Gear A.R., and Camerini D. Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation 10 (2003) 335-350
40. Lowndes S.A., and Harris A.L. Copper chelation as an antiangiogenic therapy. Oncol. Res. 14 (2004) 529-539
41. Friedl A., Stoesz S.P., Buckley P., and Gould M.N. Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochem. J. 31 (1999) 433-441
42. Chen H., Herndon M.E., and Lawler J. The cell biology of thrombospondin-1. Matrix Biol. 19 (2000) 597-614
43. Gallagher J.T. The extended family of proteoglycans: social residents of the pericellular zone. Curr. Opin. Cell Biol. 1 (1989) 1201-1218
44. Lambert C., Landau A.M., and Desbarats J. Fas-beyond death: a regenerative role for Fas in the nervous system. Apoptosis 8 (2003) 551-562
45. Ugurel S., Rappl G., Tilgen W., and Reinhold U. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. J. Clin. Oncol. 19 (2001) 577-583
46. Oster H., Abraham D., and Leitges M. Expression of the protein kinase D (PKD) family during mouse embryogenesis. Gene Expression Patterns 6 (2006) 400-408
47. Aksoy E., Goldman M., and Willems F. Protein kinase C epsilon: a new target to control inflammation and immune-mediated disorders. Int. J. Biochem. Cell Biol. 36 (2004) 183-188
48. Jackson D.N., and Foster D.A. The enigmatic protein kinase Cdelta: complex roles in cell proliferation and survival. FASEB J. 18 (2004) 627-636
49. Jaffer Z.M., and Chernoff J. p21-activated kinases: three more join the Pak. Int. J. Biochem. Cell Biol. 34 (2002) 713-717
50. Berven L.A., Willard F.S., and Crouch M.F. Role of the p70(S6K) pathway in regulating the actin cytoskeleton and cell migration. Exp. Cell Res. 296 (2004) 183-195
51. Echtermeyer F., Streit M., Wilcox-Adelman S., Saoncella F., Denhez M., Detmar M., and Goetinck F.P. Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J. Clin. Invest. 107 (2001) R9-R14
52. Sieg D.J., Hauck C.R., and Schlaepfer D.D. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J. Cell Sci. 112 (1999) 2677-2691
53. Ridley A.J., Allen W.E., Peppelenbosch M., and Jones G.E. Rho family proteins and cell migration. Biochem. Soc. Symp. 65 (1999) 111-123
54. Eastwood M., Mudera V.C., McGrouther D.A., and Brown R.A. The effect of precise mechanical loading on fibroblast populated collagen lattices: morphological changes. Cell Motil. Cytoskelet. 49 (1998) 13-21
55. Simons M., and Horowitz A. Syndecan-4-mediated signalling. Cell. Signalling 13 (2001) 855-862
56. Benini S., Perbal B., Zambelli D., Colombo M.P., Manara M.C., Serra M., Parenza M., Martinez V., Picci P., and Scotlandi K. In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type. Oncogene 24 (2005) 4349-4361
57. Mo F.E., Muntean A.G., Chen C.C., Stolz D.B., Watkins S.C., and Lau L.F. CYR61 (CCN1) is essential for placental development and vascular integrity. Mol. Cell. Biol. 22 (2002) 8709-8720
58. Martin P., and Parkhurst S.M. Parallels between tissue repair and embryo morphogenesis. Development 131 (2004) 3021-3034
59. Brigstock D.R. The CCN family: a new stimulus package. J. Endocrinol. 178 (2003) 169-175
60. Leask A., and Abraham D.J. All in the CCN family: essential matricellular modulators emerge from the bunker. J. Cell Sci. 119 (2006) 4803-4810
61. Leask A., and Abraham D.J. The control of TGFβ signaling in wound healing and fibrosis. FASEB J. 18 (2004) 816-827
62. Leask A. Scar wars: is TGFbeta the phantom menace in scleroderma?. Arthritis Res. Ther. 8 4 (2006) 213